| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |